Impact of multidisciplinary team meetings on the management of venous thromboembolism. A clinical study of 142 cases.


Journal

Journal de medecine vasculaire
ISSN: 2542-4513
Titre abrégé: J Med Vasc
Pays: France
ID NLM: 101709200

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 10 09 2019
accepted: 06 04 2020
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 21 7 2020
Statut: ppublish

Résumé

Numerous guidelines have been published on the management of venous thromboembolism (VTE). However, therapeutic decision-making may prove challenging in routine clinical practice. With this in mind, multidisciplinary team (MDT) meetings have been set up in Rennes University Hospital, France. This study sought to describe the situations discussed during MDT meetings and to assess whether the meetings bring about changes in the management of these patients. A retrospective single-center study conducted at the Rennes University Hospital included cases presented from the beginning of the MDT meetings (February 2015) up to May 2017. In total, 142 cases were presented in 15 MDT meetings, corresponding to a mean of 10±4 cases per meeting. Of these, 129 related to VTE patients: 33 provoked VTEs, 22 unprovoked VTEs, 49 cancer-related VTEs, and 25 unspecified VTEs. MDT meetings led to significant changes in the anticoagulation type (therapeutic, prophylactic, or discontinuation) and duration, but not in the anticoagulant choice (direct oral anticoagulants, vitamin K antagonists, heparins, etc.). Requests for MDT meetings are made for all VTE types, and these meetings have an impact on VTE management.

Identifiants

pubmed: 32571559
pii: S2542-4513(20)30265-0
doi: 10.1016/j.jdmv.2020.04.011
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-197

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

C Mauger (C)

Cardiology Department, Saint Malo Hospital, Saint Malo, France; Vascular Medicine unit, Rennes University Hospital, Rennes, France. Electronic address: chadi.mauger@gmail.com.

I Gouin (I)

Cellular Hematology Laboratory - Bioclinical Hemostasis, Rennes, France; Rennes 1 University, Rennes, France.

P Guéret (P)

Cellular Hematology Laboratory - Bioclinical Hemostasis, Rennes, France.

F Nedelec Gac (FN)

Cellular Hematology Laboratory - Bioclinical Hemostasis, Rennes, France.

A Baillerie (A)

Departement of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.

C Lefeuvre (C)

Oncology Department, Saint-Grégoire private hospital, Saint-Grégoire, France.

B Boutruche (B)

Medical Oncology, Centre Eugène Marquis, Rennes, France.

S Bayard (S)

Cellular Hematology Laboratory - Bioclinical Hemostasis, Rennes, France; Pediatric Department, University Hospital, Rennes, France.

V Jaquinandi (V)

Vascular Medicine unit, Rennes University Hospital, Rennes, France.

P Jégo (P)

UMR INSERM U1085, Institut de Recherche sur la Santé, l'Environnement et le Travail (IRSET), Rennes, France.

G Mahé (G)

Vascular Medicine unit, Rennes University Hospital, Rennes, France; INSERM CIC 14 14, Rennes, France. Electronic address: maheguillaume@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH